Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist's Recommendation for Medication Monitoring

Los Angeles, California Survey Completed on 06-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a consultant pharmacist's recommendation to consider ordering valproic acid and ammonia levels for a resident was acknowledged and acted upon. The resident in question had diagnoses including congestive heart failure, anemia, and psychosis, and was prescribed Depakote Delayed Release for mood disorder. The consultant pharmacist documented a recommendation in the Medication Regimen Review for the physician to consider ordering these laboratory tests to monitor the therapeutic blood level of the medication. However, the facility did not inform the resident's physician of this recommendation, and no orders for the tests were placed. The Director of Nursing confirmed that the facility's policy requires pharmacy consultant recommendations to be addressed within 14 days and that the purpose of the recommended tests was to ensure the medication was safe to administer. The facility's policy also states that recommendations should be acted upon and documented by staff or the prescriber, with the physician either accepting and acting on the suggestion or providing an explanation for disagreement. In this case, there was no documentation of action or physician response regarding the pharmacist's recommendation.

An unhandled error has occurred. Reload 🗙